A month has gone by since the last earnings report for Catalyst Pharmaceutical (CPRX). Shares have added about 0.6% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Amended Merger Agreement Represents a $3.00 All-Cash Price Increase; 25% Premium to Unaffected Share Price; Parties Committed to Closing by Mid-2026 Special Committee Determines that Victory Capital’s ...
Following Comprehensive Review, Janus Henderson Board Finds Unsolicited Third-Party Proposal Not Superior and Not in the Best Interests of the Company, its Shareholders and other Stakeholders; ...
Trian and General Catalyst Agree to Increase Merger Consideration to $52.00 Per Share in Cash for Janus Henderson Group plc and Have Made the Only Actionable Proposal Amended Merger Agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results